MoneyWorks4Me

Fredun Pharmaceuticals submits board meeting intimation

15 May 2026 Evaluate
Fredun Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026, to consider and approve Audited Financial Results & Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March, 2026; consider and recommend final dividend on the paid-up equity shares for the Financial Year ended 31st March, 2026; and consider and recommend Bonus Equity Shares subject to approval of Members of the Company.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

1453.35 -94.40 (-6.10%)
17-Aug-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1882.50
Dr. Reddys Labs. 1192.00
Cipla 1430.00
Lupin 2259.20
Zydus Lifesciences 1132.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: